The Biguanides Metformin and Buformin in Combination with 2-Deoxy-glucose or WZB-117 Inhibit the Viability of Highly Resistant Human Lung Cancer Cells

The biguanides metformin (MET) and to a lesser extent buformin (BUF) have recently been shown to exert anticancer effects. In particular, MET targets cancer stem cells (CSCs) in a variety of cancer types but these compounds have not been extensively tested for combination therapy. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakisich, Juan Sebastian, Azad, Neelam, Kaushik, Vivek, Iyer, Anand K. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409035/
https://www.ncbi.nlm.nih.gov/pubmed/30918522
http://dx.doi.org/10.1155/2019/6254269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409035/
https://www.ncbi.nlm.nih.gov/pubmed/30918522
http://dx.doi.org/10.1155/2019/6254269

Ejemplares similares